Merck KGaA, Threshold drug fails in late-stage cancer trials

FRANKFURT (Reuters) - Germany's Merck KGaA and development partner Threshold Pharmaceuticals said their experimental cancer drug evofosfamide failed to show the desired effects in two late stage studies.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro